Multi‐biomarker panel prediction model for diagnosis of pancreatic cancer

Abstract

This study demonstrates a significant diagnostic performance of the multi-marker panel in distinguishing pancreatic ductal adenocarcinoma from normal and benign pancreatic disease states, as well as patients with other cancers.